Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)

European Journal of Endocrinology

Volumn 151, Issue 4, 2004, Pages 439-446

  Mestrón, Antonio ^a   Webb, Susan M ^b   Astorga, Ricardo ^c   Benito, Pedro ^d   Catalá, Miguel ^e   Gaztambide, Sonia ^f   Gómez, José Manuel ^g   Halperín, Irene ^g   Lucas Morante, Tomás ^h   Moreno, Basilio ⁱ   Obiols, Gabriel ^j   de Pablos, Pedro ^k   Páramo, Concha ^l   Picó, Antonio ^m   Torres, Elena ⁿ   Varela, César ^o   Vázquez, José Antonio ^f   Zamora, Juana ^p   Albareda, Mercè ^a   Gilabert, Montserrat ^q   Sánchez Covisa, Miguel Aguirre ^r   Alcaraz Tafalla, Marisol ^r   Alonso Troncoso, Isabel ^r   Álvarez Escolà, Cristina ^r   Andía Melero, Victor Manuel ^r   Arranz Martín, Alfonso ^r   Arribas Palomar, Luis ^r   Ballesteros Pomar, María ^r   Beitia Martín, Juan José ^r   López, Pedro Benito ^r   Bernabeu Morón, Ignacio ^r   Blanco Carrera, Concepción ^r   Blanco Samper, Benito ^r   Boronat Cortés, Mauro ^r   Carrera Santaliestra, Maria José ^r   Castillo López, Luis ^r   Cordero Diez, Ma del Mar ^r   Costilla Martín, Enrique ^r   Cózar León, Ma Victoria ^r   Cuatrecasas Cambra, Guillem ^r   De Luís Román, Daniel Antonio ^r   de Miguel Novoa, Ma Paz ^r   De Pablos Velasco, Pedro ^r   Del Pozo Picó, Carlos ^r   Diez Gómez, Juan José ^r   Díez Hernández, Alberto ^r   Duran Rodríguez Hervada, Alejandra ^r   de Antonio, Isabel Esteva ^r   Fajardo Montañana, Carmen ^r   Forga Llenas, Lluís ^r   Fraile Saez, Ángel Luis ^r   Galvez Moreno, Ma Angeles ^r   García Centera, José Andrés ^r   Gargallo Fernández, Manuel ^r   Gavilán Villarejo, Inmaculada ^r   Gil del Álamo, Paloma ^r   Gilsanz Peral, Alberto ^r   Gippini Pérez, Antonio ^r   Gómez Balaguer, Marcelino ^r   Gómez, Luis Alberto ^r   Gorgojo Martínez, Juan José ^r   Guerrero Martínez, Eduardo ^r   Hernández Bayo, Juan Angel ^r   Hernández López, Antonio ^r   Iglesias, Pedro ^r   Illán Gómez, Fátima ^r   Jaunsolo Barranechea, Miguel Ángel ^r   Lecube Torelló, Albert ^r   Liante Peñambía, Gaspar ^r   López dela Torre Casares, Martin ^r   López Hernández, Elena ^r   López López, José ^r   López Guzmán, Antonio ^r   Lucas Martín, Ana ^r   Marazuela Azpiroz, Mónica ^r   Marco Martínez, Amparo ^r   Marco Mur, Ángel Luis ^r   Martin Castillo, Fidel ^r   Martín González, Tomás ^r   Martínez Brocca, Maria Asunció ^r   Megia Colet, Ana ^r   Merino Torres, Juan Francisco ^r   Morales Gorría, Ma José ^r   Morales Perez, Francisco ^r   Murillo Sanchis, Jesús ^r   Muros de Fuentes, Ma Teresa ^r   Páramo Fernández, Concepción ^r   Pavón de Paz, Isabel ^r   Pazos Toral, Fernando ^r   Pérez Corral, Ma Begoña ^r   Pérez Pérez, Antonio ^r   Pi Barrio, J Javier ^r   Piedrola Morato, Gonzalo ^r   Pou Torelló, José Ma ^r   Puigdevall Gallego, Victor ^r   Rodríguez Guerrero, Paloma ^r   Rodríguez Roble, Azuzena ^r   Romero Bobillo, Enrique ^r   Ruano Vieitez, Belén ^r   more..

^a HOSPITAL DOS DE MAIG   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^l HOSPITAL XERAL CÍES   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

ⁿ HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^o HOSPITAL RAMÓN Y CAJAL   (Spain)

^p University Hospital of Alicante   (Spain)

^q Oncology Unit   (Spain)

^r Novartis Farmacéutica ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; BREAST CANCER; CARDIOVASCULAR DISEASE; CARPAL TUNNEL SYNDROME; CAUSE OF DEATH; CLINICAL FEATURE; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GOITER; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROIMAGING; NEUROSURGERY; ONLINE SYSTEM; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; REGISTER; REVIEW; SLEEP APNEA SYNDROME; SPAIN; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL FIELD;

ACROMEGALY; ADULT; FEMALE; GROWTH HORMONE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; SPAIN;

EID: 7244257406     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510439     Document Type: Review

References (40)

1. Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T & Hadden DR. Ascertainment and natural history of treated acromegaly in Northern Ireland. Ulster Medical Journal 1990 59 55-62.
2. Bengtsson BA, Eden S, Ernest I, Oden A & Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica 1988 223 327-335.
3. Etxabe J, Gaztambide S, Latorre P & Vázquez JA. Acromegaly: an epidemiological study. Journal of Endocrinological Investigation 1993 16 181-187.
4. Holdaway IM & Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999 2 29-41.
5. Monson JP. The epidemiology of endocrine tumours. Endocrine-Related Cancer 2000 7 29-36.
6. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K & Melmed S. Criteria of cure of acromegaly. A consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529.
7. O'Fallon JR, Dubey SB, Salsburg DS, Edmonson A & Soffer T. Should there be statistical guidelines for medical research papers? Biometrics 1978 34 687-695.
8. Instituto Nacional de Estadística. INEBASE Censo 2001. www.ine.es
9. Rajasoorya. C, Holdaway IM, Wrightson P, Scott DJ & Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology 1994 41 95-102.
10. Kauppinen-Markelin RM, Niskanen L, Voutilainen E, Salmela P, Ebeling T, Salmi J, Jaatinen P, Viikari J, Välimäki MJ & Sane T. Treatment of acromegaly in Finland: a National survey. In Proceedings of the 34th International Symposium on GH and Growth Factors in Endocrinology and Metabolism, Budapest, 2002 Abstract F4.
11. Beauregard C, Truong U, Hardy J & Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology 2003 58 86-91.
12. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM & Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 1613-1617.
13. del Pozo C, Webb SM, Oliver B, Tresserras P & de Leiva A. Tratamiento de la acromegalia. Resultados en 56 pacientes. Medicina Clínica 1990 94 85-87.
14. Barceló B, Pérez C, Davila N, Lucas T, Salto L & Alcañiz J. Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both. Medicina Clinica 1983 80 735-741.
15. Alexander L, Appleton D, Hall R, Ross WM & Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology 1980 12 71-79.
16. Osman IA, James RA, Chatterjee S, Mathias D & Kendall-Taylor P. Factors determining the long-term outcome of surgery for acromegaly. Quarterly Journal of Medicine 1994 87 617-623.
17. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM & Wass JAH. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clinical Endocrinology 1996 45 407-413.
18. Swearingen B, Barker F, Katznelson L, Biller B, Grinspoon S, Klibanski A, Moayeri N, Black PM & Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism 1998 83 3419-3426.
19. Pardo S, Albareda M, Webb SM, Oliver B & Bartumeus F. Tratamiento quirúrgico: indicaciones y resultados. In Acromegalia pp 169-187. Ed. SM Web. Barcelona: Acción Médica, 1998.
20. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB & Wass JAH. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clinical Endocrinology 1999 50 561-567.
21. Lucas Morante T, García-Uría J, Estrada J, Saucedo G, Cabello A, Alcañiz J & Barceló B. Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery. Journal of Neurosurgery 1994 81 10-14.
22. Biermasz N, Van Dulken H & Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Journal of Clinical Endocrinology and Metabolism 2000 85 4596-4602.
23. Jenkins D, O'Brien I, Johnson A, Shakespear R, Sheppard MC & Stewart PM. The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clinical Endocrinology 1995 43 517-522.
24. Yamada S, Aiba T, Takada K, Ozawa Y, Shimizu T, Sawano S, Shishiba Y & Sano T. Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome. Clinical Endocrinology 1996 45 291-298.
25. Lisset CA, Peacey SR, Laing I, Tetlow L, Davis JR & Shalet SM. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone secreting adenoma. Clinical Endocrinology 1998 49 653-657.
26. Gittoes NJ, Johnson AP, Sheppard MC & Stewart PM. Outcome of surgery for acromegaly: the experience of a single surgeon. Quarterly Journal of Medicine 1999 92 741-745.
27. Clayton RN, Stewart PM, Shalet SM & Wass JAH. Pituitary surgery for acromegaly: should be done by specialists. British Medical Journal 1999 319 588-589.
28. Bondanelli M, Ambrosio MR & degli Uberti EC. Pathogenesis and prevalence of hypertension in acromegaly.Pituitary 2001 4 239-249.
29. Fatti LM, Scacchi M, Pincelli AI, Lavezzi E & Cavagnini F. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 2001 4 259-262.
30. Weiss V, Sonka K, Pretl M, Dostalova S, Klozar J, Rambousek P, Marek J & Haas T. Prevalence of the sleep apnea syndrome in acromegaly population. Journal of Endocrinological Investigation 2000 23 515-519.
31. Melmed S. Acromegaly and cancer: not a problem? Journal of Clinical Endocrinology and Metabolism 2001 86 2929-2934.
32. Jenkins PJ & Besser M. Clinical perspective: acromegaly and cancer: a problem. Journal of Clinical Endocrinology and Metabolism 2001 86 2935-2941.
33. Webb SM, Casanueva FF & Wass JAH. Oncological complications of excess GH in acromegaly. Pituitary 2002 5 21-25.
34. Bates AS, Van't Hoff W, Jones JM & Clayton RN. An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine 1993 86 293-299.
35. Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734.
36. Nabarro JD. Acromegaly. Clinical Endocrinology 1987 26 481-512.
37. Ron E, Gridley G, Hrubec Z, Page W, Arora S & Fraumeni JE Acromegaly and gastrointestinal cancer. Cancer 1991 68 1673-1677.
38. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z & Marinkovic J. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clinical Endocrinology 1998 49 441-445.
39. Holdaway IM, Rajasoorya RC, Wong J, Orr-Walker B, Gamble G. Pituitary Tumors. Epidemiology, Pathogenesis and Management, pp 31-42. Ed. SM Webb. Bristol: BioScieritifica Ltd, 1998.
40. Holdaway IM, Rajasoorya RC & Gamble G. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674.